Drug-resistance of HIV
Conditions
Interventions
Opioid HIV+ group:none
Non-Opioid HIV+ group:none
Sponsors
Guangxi Medical University
Eligibility
Sex/Gender
All
Age
19 Years to 87 Years
Inclusion criteria
Inclusion criteria: 1. Opioid HIV+ group (1) Aged 18 years or older male and female; (2) Han / Zhuang people; (3) History of drug abuse / methadone use; (4) AIDS status: HIV+; (5) Viral load: > 1000cp/ml; (6) Status of hiv treatment: no / has been treated with HAART. 2. Non-Opioid HIV+ group (1) Aged 18 years or older male and female; (2) Han / Zhuang people; (3) No history of drug abuse / methadone use; (4) AIDS status: HIV+; (5) Viral load: > 1000cp/ml; (6) Status of hiv treatment: no / has been treated with HAART.
Exclusion criteria
Exclusion criteria: 1. Opioid HIV+ group (1) Risk factor:They discontinued methadone for more than 15 consecutive days or breaks for more than 30 days in the past 6 months; (2) Health status: major chronic diseases (heart, kidney, lung, endocrine, metabolic or autoimmune diseases and tuberculosis). 2. Non-Opioid HIV+ group (1) Risk factor:Addicted to any kind of drug; (2) Health status: major chronic diseases (heart, kidney, lung, endocrine, metabolic or autoimmune diseases and tuberculosis).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HIV-1 drug resistance mutation; | — |
Countries
China
Contacts
Public ContactHuang Jiegang
Guangxi Medical University
Outcome results
None listed